E-Prescribing Market

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of e-Prescribing
6.2.1. Key Characteristics of e-Prescribing
6.2.2. Key Applications of the e-Prescribing
6.2.3. Challenges Associated with e-Prescribing

6.3. Future Perspective

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. e-Prescribing Service Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size

7.2.3. e-Prescribing Solution Providers: Overall Market Landscape
7.2.3.1. Analysis by Product Type
7.2.3.2. Analysis by Deployment Type
7.2.3.3. Analysis by Component Type
7.2.3.4. Analysis by Usage Method Type
7.2.3.5. Analysis by Substance Type
7.2.3.6. Analysis by System Type
7.2.3.7. Analysis by Specialty Type
7.2.3.8. Analysis by End User

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: e-Prescribing Providers
8.4.1. e-Prescribing Providers Based in North America (Peer Group 1)
8.4.2. e-Prescribing Providers Based in Europe (Peer Group 2)
8.4.3. e-Prescribing Providers Based in Asia-Pacific (Peer Group 3)
8.4.4. e-Prescribing Providers Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Athenahealth
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar detail is presented for other below mentioned companies based on information in the public domain

9.3. Cerner (Oracle)
9.4. Change Healthcare
9.5. DrFirst
9.6. eClinicalWorks
9.7. Epic Systems
9.8. Henry Schein
9.9. McKesson
9.10. NXGN Management
9.11. Networking Technology (RXNT)
9.12. Practice Fusion
9.13. Parachute Health
9.14. RelayHealth
9.15. Surescripts
9.16. Veradigm (AllScripts Healthcare)

10. SWOT ANALYSIS

11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL E-PRESCRIBING MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global e-Prescribing Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario

12.6. Key Market Segmentations

13. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix

13.6. e-Prescribing Market for Solution: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.1. e-Prescribing Market for Integrated Solutions: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.6.2. e-Prescribing Market for Standalone Solutions: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.7. e-Prescribing Market for Service: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.1. e-Prescribing Market for Implementation: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.2. e-Prescribing Market for Training: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
13.7.3. e-Prescribing Market for Network: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

13.8. Data Triangulation and Validation

14. MARKET OPPORTUNITIES BASED ON TYPE OF DEPLOYMENT
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. e-Prescribing Market for On-Premise: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.7. e-Prescribing Market for Web-Based / Cloud Based: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
14.8. Data Triangulation and Validation

15. MARKET OPPORTUNITIES BASED ON TYPE OF COMPONENT
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. e-Prescribing Market for Hardware: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.7. e-Prescribing Market for Software: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.8. e-Prescribing Market for Services: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
15.9. Data Triangulation and Validation

16. MARKET OPPORTUNITIES BASED ON TYPE OF USAGE METHOD
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. e-Prescribing Market for Handheld Devices: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.7. e-Prescribing Market for Computer-Based Devices: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.8. Data Triangulation and Validation

17. MARKET OPPORTUNITIES BASED ON TYPE OF SUBSTANCE
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. e-Prescribing Market for Controlled Substance: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.7. e-Prescribing Market for Non-Controlled Substance: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.8. Data Triangulation and Validation

18. MARKET OPPORTUNITIES BASED ON TYPE OF SYSTEM
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. e-Prescribing Market for Integrated e-Prescribing Systems: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.7. e-Prescribing Market for Standalone e-Prescribing Systems: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.8. Data Triangulation and Validation

19. MARKET OPPORTUNITIES BASED ON TYPE OF SPECIALTY
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. e-Prescribing Market for Oncology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.7. e-Prescribing Market for Sports Medicine: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.8. e-Prescribing Market for Neurology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.9. e-Prescribing Market for Cardiology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.10. e-Prescribing Market for Other Specialties: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.11. Data Triangulation and Validation

20. MARKET OPPORTUNITIES BASED ON TYPE OF END USER
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. e-Prescribing Market for Hospitals: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.7. e-Prescribing Market for Office-Based Physicians: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.8. e-Prescribing Market for Other Pharmacies: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.9. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR E-PRESCRIBING IN NORTH AMERICA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. e-Prescribing Market in North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.1. e-Prescribing Market in the US: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.2. e-Prescribing Market in Canada: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.3. e-Prescribing Market in Mexico: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR E-PRESCRIBING IN EUROPE
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. e-Prescribing Market in Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.1. e-Prescribing Market in the France: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.2. e-Prescribing Market in Germany: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.3. e-Prescribing Market in Italy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.4. e-Prescribing Market in Spain: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.5. e-Prescribing Market in UK: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.6. e-Prescribing Market in Rest of the Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR E-PRESCRIBING IN ASIA-PACIFIC
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix

23.6. e-Prescribing Market in Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.1. e-Prescribing Market in China: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.2. e-Prescribing Market in India: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.3. e-Prescribing Market in Japan: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
23.6.4. e-Prescribing Market in Rest of the Asia-Pacific: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

23.7. Data Triangulation and Validation

24. MARKET OPPORTUNITIES FOR E-PRESCRIBING IN MIDDLE EAST AND NORTH AFRICA (MENA)
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix

24.6. e-Prescribing Market in Middle East and North Africa (MENA): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
24.6.1. e-Prescribing Market in Egypt: Historical Trends (Since 2019) and Forecasted Estimates (Till 20.5)
24.6.2. e-Prescribing Market in Saudi Arabia: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
24.6.3. e-Prescribing Market in United Arab Emirates (UAE): Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

24.7. Data Triangulation and Validation

25. MARKET OPPORTUNITIES FOR E-PRESCRIBING IN LATIN AMERICA
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix

25.6. e-Prescribing Market in Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
25.6.1. e-Prescribing Market in Argentina: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
25.6.2. e-Prescribing Market in Brazil: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

25.7. Data Triangulation and Validation

26. TABULATED DATA

27. LIST OF COMPANIES AND ORGANIZATIONS

28. CUSTOMIZATION OPPORTUNITIES

29. ROOTS SUBSCRIPTION SERVICES

30. AUTHOR DETAIL